Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: Evidence for a 'graft vs. myelofibrosis' effect

British Journal of Haematology

Volumn 108, Issue 2, 2000, Pages 430-433

  Byrne, J L ^a   Beshti, H ^a   Clark, D ^b   Ellis, I ^a   Haynes, A P ^a   Das Gupta, E ^a   Russell, N H ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Allogeneic transplantation; Donor leucocyte infusion; Graft vs. myelofibrosis; Myelofibrosis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHIMERA; DISEASE COURSE; DONOR; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKOCYTE TRANSFUSION; MALE; MYELOFIBROSIS; PRIORITY JOURNAL; RELAPSE; REMISSION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

CHRONIC DISEASE; GRAFT VS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTE TRANSFUSION; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MYELOFIBROSIS; REMISSION INDUCTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034057313     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01826.x     Document Type: Article

References (9)

1. Anderson, J., Sale, G., Appelbaum, F., Chauncey, T. & Storb, R. (1997) Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis. British Journal of Haematology, 98, 1010-1016.
2. Bauermeister, D. (1971) Quantification of bone marrow fibrosis - a normal range. American Journal of Clinical Pathology, 56, 24-27.
3. Creemers, G., Lowenberg, B. & Hagenbeek, A. (1992) Allogeneic bone marrow transplantation for primary myelofibrosis. British Journal of Haematology, 82, 158-162.
4. Guardiola, P., Esperou, H., CazalsHatem, D., Ifrah, N., Jouet, J., Buzyn, A., Sutton, L., Gratecos, N., Tilly, H., Liore, B. & Gluckman, E. (1997) Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. British Journal of Haematology, 98, 1004-1009.
5. Guardiola, P., Anderson, J., Bandini, G., Cervantes, F., Runde, V., Arcese, W., Bacigalupo, A., Przepiorka, D., O'Donnell, M., Polchi, P., Buzyn, A., Sutton, L., Cazals-Hatem, D., Sale, G., deWitte, T., Deeg, H. & Gluckman, E. (1999) Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano Peril Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Center Collaborative Study. Blood, 9, 2831-2828.
6. Mackinnon, S., Papadopoulos, E., Carabasi, M., Reich, L., Collins, N., Boulad, F., Castro-Malaspina, H., Childs, B., Gillio, A. & Kernan, N. (1995) Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation - separation of graft-versus-leukemia responses from graft-versus-host disease. Blood, 86, 1261-1268.
7. Miflin, G., Stainer, C.J., Carter, G.I., Byrne, J.L., Haynes, A.P. & Russell, N.H. (1999) Comparative serial measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bone marrow. British Journal of Haematology 107, 429-440.
8. Przpiorka, D., Giralt, S., Khouri, I., Champlin, R. & Bueso-Ramos, C. (1998) Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases. American Journal of Hematology, 57, 24-29.
9. Singhal, S., Powles, R., Treleaven, J., Pollard, C., Lumley, H. & Mehta, J. (1995) Allogeneic bone marrow transplantation for primary myelofibrosis. Bone Marrow Transplantation, 16, 743-746.